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Article
Tibialis posterior tendon dysfunction (TPTD) is a common 
tendinopathy that is associated with adult acquired flatfoot 
deformity.6,11,13,22 Therapeutic options for stage II TPTD 
entail nonoperative care with bracing and exercise or oper-
ative management.7,20,21,30,31 The severity of TPTD may 
affect the choice of nonoperative or operative treatment. 
Stage II TPTD is characterized by signs of tendinopathy 
(ie, pain and swelling along the tendon) in the presence of 
a passively correctable foot deformity or loss of the medial 
longitudinal arch.13 Stage II TPTD is associated with a 
wide range of weakness, foot deformity, and functional 
problems.17,33,34 Ultimately, relatively few participants 
with TPTD, 12.5% to 27% in recent studies, elect operative 
management.28,30 The low use of operative management of 
TPTD emphasizes the need to optimize nonoperative 
treatments.
579906 FAIXXX10.1177/1071100715579906Foot & Ankle InternationalHouck et al
research-article2015
1George Fox University, Department of Physical Therapy, Newberg, OR, 
USA
2SUNY Upstate Medical University, Syracuse, NY, USA
3University of Rochester Medical Center, Department of Orthopedic 
Surgery, Rochester, NY, USA
4Ithaca College–Movement Analysis Laboratory, Ithaca, NY, USA
Corresponding Author:
Jeff Houck, PT, PhD, George Fox University, Program of Physical 
Therapy, Newberg, OR 97132. 
Email: jhouck@georgefox.edu
Randomized Controlled Trial Comparing 
Orthosis Augmented by Either Stretching  
or Stretching and Strengthening for  
Stage II Tibialis Posterior Tendon 
Dysfunction
Jeff Houck, PT, PhD1, Christopher Neville, PT, PhD2, Josh Tome, MS4,  
and Adolph Flemister, MD3
Abstract
Background: The value of strengthening and stretching exercises combined with orthosis treatment in a home-based 
program has not been evaluated. The purpose of this study was to compare the effects of augmenting orthosis treatment 
with either stretching or a combination of stretching and strengthening in participants with stage II tibialis posterior tendon 
dysfunction (TPTD).
Methods: Participants included 39 patients with stage II TPTD who were recruited from a medical center and then 
randomly assigned to a strengthening or stretching treatment group. Excluding 3 dropouts, there were 19 participants in 
the strengthening group and 17 in the stretching group. The stretching treatment consisted of a prefabricated orthosis 
used in conjunction with stretching exercises. The strengthening treatment consisted of a prefabricated orthosis used 
in conjunction with the stretching and strengthening exercises. The main outcome measures were self-report (ie, Foot 
Function Index and Short Musculoskeletal Function Assessment) and isometric deep posterior compartment strength. 
Two-way analysis of variance was used to test for differences between groups at 6 and 12 weeks after starting the exercise 
programs.
Results: Both groups significantly improved in pain and function over the 12-week trial period. The self-report measures 
showed minimal differences between the treatment groups. There were no differences in isometric deep posterior 
compartment strength.
Conclusions: A moderate-intensity, home-based exercise program was minimally effective in augmenting orthosis wear 
alone in participants with stage II TPTD.
Level of Evidence: Level I, prospective randomized study.
Keywords: rehabilitation, tendinopathy, foot
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Orthosis prescription, including above-ankle and below-
ankle orthoses, are the most commonly recommended non-
operative treatment.28 Uncontrolled studies note that 
participants experience a decrease in pain and improved 
function when using orthoses.1,2,14,17,20 Further, long-term 
(4- to 8-year) follow-up of orthoses suggested that 60.6% of 
participants were “satisfied.” However, the average initial 
length of orthosis wear was 14.9 months, and 36% of the 
participants returned to wearing their orthosis at some time 
during the follow-up period. Intermittent continuing use of 
an orthosis suggests unresolved symptoms over prolonged 
periods. Two unaddressed issues are (1) whether some 
orthosis strategies are more effective than others and (2) 
whether other treatments, such as exercise, augment ortho-
sis use.
A prefabricated clamshell orthosis may be cost-effective 
and adequate for foot support in patients with TPTD. A 
kinematic study showed that a prefabricated clamshell 
orthosis limited hindfoot eversion and raised the medial 
longitudinal arch.27 These same movements in a cadaver 
study demonstrated unloading of the tibialis posterior ten-
don.23,26 These positive kinematic findings are coupled with 
positive outcomes in studies that use the prefabricated 
clamshell orthoses.14 Considering the markedly lower cost 
of the prefabricated clamshell orthosis and the demon-
strated clinical benefits,14 this type of orthosis was consid-
ered a good choice for clinical management.
The conflicting evidence regarding whether exercise 
augments orthosis wear in patients with stage II TPTD 
stems from varying study design (uncontrolled vs con-
trolled trials), orthosis use (wide range), and exercise dos-
age. First, uncontrolled trials demonstrate the potential 
benefit of combining an orthosis and exercise programs for 
stage II TPTD.1,16 However, only 1 of 2 controlled trials 
demonstrated a similar benefit.17 Second, orthotic designs 
that restrict ankle and foot motion may induce muscle dis-
use.25 Whether combining exercise with less restrictive 
orthoses maintains muscle function and similar clinical 
benefits is unclear. Third, the optimal intensity of training is 
undetermined. One uncontrolled trial suggested marked 
improvements as a result of high-intensity training.1 Two 
randomized controlled trials3,17 included lower dosage 
training and did not replicate the positive results of a high-
intensity dosage.1 Untested is the effect of a program that 
may be easily used in the clinic with moderate-intensity 
exercise to improve muscle weakness and improve pain-
free function.
The purpose of this study was to examine the effects of 
strengthening treatment combined with orthosis and stretch-
ing compared with the effects of orthosis and stretching 
alone in participants with stage II TPTD. The dosage for the 
strengthening treatment group was as high as possible with 
the limit being that the exercises would need to primarily be 
performed in the home and within patient tolerance.
Methods
Participants
From spring 2007 to summer 2009, a total of 88 participants 
were screened for participation in this study. Of the 88 par-
ticipants who were screened, a total of 39 were admitted to 
the study. A power analysis, based on pilot data on strength 
and self-reported outcomes, suggested that a sample size of 
20 per group would provide greater than 80% power to detect 
differences between the groups at an effect size equal to 0.75 
the standard deviation of the measures used. Recruitment 
was conducted at a university medical clinic by a foot and 
ankle fellowship–trained physician. To qualify for the study, 
participants met the following criteria to be diagnosed with 
stage II TPTD: (1) presence of either pain or swelling along 
the course of the tibialis posterior tendon and (2) presence of 
correctable flatfoot deformity. Participants also had to be able 
to walk 15 m and were required to be older than 40 years. 
Participants were excluded if (1) they were unable to walk 15 
m, (2) a test using Semmes-Weinstein 5.06 monofilament 
showed decreased sensation, (3) participants had an arch 
height index of less than 0.255 (2 SD below arch height index 
of controls),5 (4) participants were unable to assume subtalar 
neutral posture, or (5) they had bilateral TPTD. Participants 
with inflammatory arthropathies (rheumatoid arthritis, psori-
asis) and comorbidities for foot conditions (hallux rigidus, 
plantar fasciitis) were also excluded. Participants signed a 
consent form approved by the institutional review board at 
the University of Rochester and Ithaca College. This clinical 
trial was registered at ClinicalTrials.gov in 2008.
Randomization and Blinding
A stratified block randomization protocol was used to assign 
participants to the stretching or strengthening group. 
Participants were stratified, according to their Foot Function 
Index (FFI) Total score, into moderate/severe (FFI-Total 20 
or more) and minimal (FFI-Total less than 20) categories. 
Participants in the moderate/severe and minimal groups were 
randomized separately into the stretching (orthosis and 
stretching) and strengthening (orthosis, stretching, and 
strengthening) groups to ensure equal distribution on severity 
of the FFI-Total score. Allocation was not concealed. 
However, to ensure randomization, an independent investiga-
tor tracked the assignment to groups throughout the experi-
ment. Once participants were admitted to a particular study 
protocol, all participants were told they were in the interven-
tion group. However, the treating therapist administered both 
interventions.
Interventions
Stretching Group (Orthosis and Stretching). All participants 
were provided and fit with an orthosis (AirLift TPTD, 
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Aircast, DJO Global Inc, Vista, CA) that includes an ankle 
stirrup support and medial longitudinal arch support, com-
monly used for TPTD. The prefabricated orthosis has dem-
onstrated validity for improving foot kinematics during 
walking.25 In addition to wearing the orthosis during all 
weight-bearing activities, participants were provided with 
written descriptions and pictures demonstrating exercises 
that included a wall calf stretch and a supine ankle active 
range of motion exercise. The wall calf stretch included a 
knee-extended gastrocnemius stretch and a knee-flexed 
soleus stretch. For the foot and ankle active range of motion 
stretch, instructions were to point the big toe down (ie, plan-
tar flexion) while moving it toward the other foot (ie, inver-
sion) and then point the toe up (ie, dorsiflexion) and away 
from the other foot (ie, eversion). This movement is known 
to stretch the tibialis posterior muscle.9 It is also anecdotally 
associated with pain relief. Participants were instructed to 
perform 3 sets of the stretching exercises, 2 times a day. 
Each stretching exercise was performed twice and held for 
30 seconds. The effects of these 2 exercises were not 
expected to cause muscle hypertrophy.
Strengthening Group (Strengthening Combined With Orthosis 
and Stretching). The strengthening exercises included a pro-
gression of 3 exercises that were meant to restore the ability 
of participants with TPTD to perform a single-leg heel raise 
(see the Appendix in the online Supplemental Materials).
1. Bilateral heel raises (standing)
2. Ankle plantar flexion with foot adduction and hind-
foot inversion (side-lying or seated) with elastic 
bands (Thera-Band, Hygenic Corporation, Akron, 
OH).
3. Unilateral heel raises (standing)
The focus for each of the strengthening exercises was to 
progressively load the tibialis posterior tendon and ankle 
plantar flexors. This included both eccentric and concentric 
contractions during the elastic band exercise and a deliber-
ate focus on raising the arch and inverting the hindfoot dur-
ing the heel-raise exercises. A recent study noted moderate 
contribution of the tibialis posterior muscle during a heel 
raise.15 The seated elastic band exercise for the subtalar 
inverters complied with published recommendations.10 
Participants sat cross-legged with the ankle plantar flexed. 
An elastic band was wrapped around the forefoot and 
anchored with the opposite leg on the floor. Participants 
were then asked to invert and adduct their foot against the 
resistance of the band, effectively raising their foot toward 
the ceiling. They were taught not to substitute with their 
tibialis anterior muscle. Participants were encouraged to 
exercise to exhaustion against the heaviest resistance bands 
that could be provided and perform the heel-raise exercises 
to the target number and height. Participants were pro-
gressed at each visit they attended throughout the program 
so long as they (1) could execute the exercise and (2) did 
not experience significant pain in the tibialis posterior ten-
don. The goal was for participants to progress to 3 sets of 30 
repetitions, 2 times per day for each exercise. Participants 
were told that muscle soreness in the leg was a normal 
response to the exercise. The participants in the strengthen-
ing group (orthosis and strengthening) performed the same 
exercises as the stretching group as well as the strengthen-
ing exercises.
Participants in both the stretching and strengthening 
treatment groups were seen a total of 7 sessions (initial, 
week 1, week 2, week 3, week 4, week 5, and week 6). The 
initial visit was used to complete tests and orient partici-
pants to the exercises, and the week 1 to week 3 sessions 
were used to teach correct technique and progress resistance 
as indicated. The week 4 through week 6 sessions were used 
to answer questions and encourage compliance and pro-
gression. From week 6 until the follow-up at 12 weeks, par-
ticipants were encouraged to continue with their exercises 
independently. All sessions, for both the stretching and 
strengthening groups, lasted approximately 30 minutes, 
ensuring that both groups received approximately the same 
amount of attention.
A compliance log was used to encourage follow-through 
and record orthosis wear and exercise sets. At the end of 
study participation, the compliance log was collected, and 
the hours of orthosis wear and sets completed were tallied. 
The number of wear hours and number of sets performed by 
each participant were divided by the total possible orthosis 
wear hours (8 hours per day × total days [12 weeks × 7 days 
per week]) and total sets possible (2 sets per day × total days 
[12 weeks × 7 days per week]). Each participant’s total 
brace wear time and sets completed were then expressed as 
a percentage of total possible to document compliance.
Outcome Variables
Foot Function Index. The FFI is a validated questionnaire 
previously used to document outcomes in TPTD.2-4 The 
test-retest reliability, internal consistency, and factor analy-
sis of the original scale support the construct validity for 
patients with TPTD.4,8,19,29 The 3 domains of the FFI include 
pain (FFI-Pain), disability (FFI-Disability), and activity 
limitations (FFI-Activity Limitations). Each category asks 
participants to rate items relative to pain. The average of the 
3 scales is the FFI-Total. The reported minimal clinically 
important difference is 12.3 mm for FFI-Pain, 6.7 mm for 
FFI-Disability, undetermined for FFI-Activity Limitations, 
and 6.5 mm for FFI-Total.18
Short Musculoskeletal Function Assessment. The Short Mus-
culoskeletal Function Assessment (SMFA) is a self-report 
 at GEORGE FOX UNIVERSITY on September 2, 2016fai.sagepub.comDownloaded from 
Houck et al 1009
questionnaire consisting of the Mobility Index, Dysfunction 
Index, and Bother Index. The Dysfunction Index is used to 
assess patients’ perceptions of their functional performance, 
while the Bother Index is used to assess participants’ per-
ceptions of how much they are bothered by problems. The 
Mobility Index is a subset of questions specific to commu-
nity ambulation. Note that pain is not mentioned in the 
questionnaire, making this outcome distinct from the FFI. 
The scale was originally validated in participants who had 
acute fracture or soft tissue injury.32 The responsiveness to 
change of the SMFA is 10 points out 100 for each scale 
(function, Mobility, and Bother Indexes).32
Isometric Deep Posterior Compartment Strength
Maximal efforts of isometric deep posterior compartment 
were used to document strength. A custom-made isometric 
strength testing system that isolated the deep posterior com-
partment by resisting foot adduction was used.12 A force 
transducer (Model SML-200, Interface, Scottsdale, AZ), 
connected in series with a resistance plate and oscilloscope 
(TDS 410A, Tektronix, Beaverton, OR) was used to display 
force readings. Participants were seated with their leg in an 
air stirrup brace (Aircast Inc) mounted on uprights. The air 
stirrup brace was adjusted so the heel was approximately 10 
cm above the resistance plate, resulting in 30 to 45 degrees 
of ankle plantar flexion depending on foot length. The resis-
tance plate was mounted on ball-bearing tracks in the 
medial-lateral direction, and moleskin was used to fit to the 
general shape of the medial forefoot. The result was that 
participants could exert maximum effort against the resis-
tance plate (medial direction) with little discomfort.
Visual feedback of the amount of force exerted and elec-
tromyography of the tibialis anterior muscle for each effort 
was used to encourage participants to exert maximal efforts 
and minimize contribution of the tibialis anterior. A surface 
electrode (DE-2.1, Delsys Inc, Boston, MA) placed over the 
tibialis anterior was tracked using electromyography 
(Bangoli-2 EMG System, Delsys Inc) and displayed on the 
oscilloscope. The force and muscle activity results were 
used to provide feedback to the examiner and participants.
Participants were instructed to “press down and in” to 
reproduce a maximum plantar flexion, subtalar inversion, 
and forefoot adduction effort. To track substitution by the 
tibialis anterior muscle, electromyography was used. 
Maximal ankle dorsiflexion efforts were recorded and used 
to calculate 10% of the maximum peak to peak electromyo-
graphic signal. During 5 submaximal efforts, if tibialis ante-
rior muscle activity was high (exceeded 10% of maximum 
voluntary contraction), participants were given verbal cues 
to reduce tibialis anterior muscle activity (push down harder 
and/or push medially with their forefoot), diminishing the 
contribution of the tibialis anterior muscle. After the prac-
tice trials, visual feedback of the force and verbal 
encouragement were used to motivate participants to exert 
3 maximal efforts. The average of the peak force was used 
to document the peak isometric deep posterior compartment 
strength. A previous study demonstrated adequate reliabil-
ity with intraclass correlation coefficients above 0.87 and a 
standard error of measurement of 0.14 N/kg.12
Statistical Analysis
Two-way mixed-effect analysis of variance (ANOVA) mod-
els were used to analyze differences between groups on the 
dependent variables (ie, self-report scores and isometric 
deep posterior compartment strength). The 2 factors of each 
model were time and group. Time included 3 time points 
(initial, 6 weeks, and 12 weeks). The second factor, group, 
included 2 levels designated the strengthening and stretch-
ing groups. Differences between interventions at either time 
point (6 weeks or 12 weeks) were consistent with significant 
interaction effects (group × time). In the presence of a sig-
nificant main effect for time, pairwise comparisons between 
time points were completed (initial, 6 weeks, and 12 weeks). 
To further investigate comparisons between the groups, 
changes between each of the time points (initial to 6 weeks, 
initial to 12 weeks, and 6 weeks to 12 weeks) were calcu-
lated. Further, the percentage of participants who made 
improvements on the FFI above a minimal clinically impor-
tant difference, and on the SMFA equal to or above respon-
siveness (10 points), were identified and compared using a 
nonparametric chi-square analysis. For deep posterior com-
partment strength, the standard error of the measurement 
(0.14 N/kg) was used to determine improvements in strength. 
An alpha level of .05 was used for each analysis. The depen-
dent variables analyzed included the subscales of the FFI 
(Activity Limitations, Disability, Pain, and Total), subscales 
of the SMFA (Mobility, Function, and Bother Indexes), and 
isometric deep posterior compartment strength.
Results
Recruitment and Retention
Eighty-eight participants were screened for the study, with 
39 meeting the study criteria (Figure 1). Of the 39 partici-
pants, 20 were randomized to the strengthening treatment 
group while 19 were randomized to the stretching treatment 
group. There were no significant differences between any of 
the subjects’ initial characteristics (Table 1). One partici-
pant in the strengthening treatment group decided to have 
surgery after the 2-week follow-up (Figure 1). In the stretch-
ing group, 2 participants were lost between the 6- and 
12-week follow-ups. Data for these 3 participants were not 
included in the final analysis. Compliance for completing 2 
sets of exercise per day for the 12 weeks of the study for 
both of the groups ranged from 29% to 126% (average 
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79%) for all participants completing the study. Compliance 
for wearing the orthosis ranged from 6 to 15 hours per day 
(average 9.9 hours). There were no significant differences 
between the groups in compliance with exercise or orthosis 
wear. Additionally, there were no recorded adverse events 
from exercise (extreme muscle soreness, increase medial 
ankle pain) or orthosis wear (blisters, calluses, increased 
pain). All participants were analyzed in the groups to which 
they were originally assigned, and data collection was ter-
minated when study sample approximated the anticipated 
recruitment goals.
Foot Function Index
For all FFI dependent variables, there were significant main 
effects for time, indicating that both groups improved over 
time (Table 2). For all FFI dependent variables, 6- and 
12-week time points were associated with significantly bet-
ter scores compared with initial scores. However, there 
were no significant differences between the 6-week and 
12-week time points for any of the FFI dependent variables. 
There were also no significant differences in change scores 
between the strengthening and stretching groups associated 
with the FFI from initial to 6 weeks or from initial to 12 
weeks (Table 3). Change scores on the FFI were similar 
from 6 to 12 weeks. The proportions of participants experi-
encing a significant change was not significant for all inter-
vals assessed for the FFI.
SMFA Questionnaire
For all SMFA dependent variables, there were significant 
main effects for time, indicating that both groups improved 
over time (Table 2). For all SMFA dependent variables, 6- and 
Enrollment and randomizaon, 
n = 39
Assessed for eligibility, n = 88
Excluded n = 49
Inclusion Criteria Not met(see 
text for details);
(Presence of comorbidity n=20, 
Decreased sensaon n=4, Arch 
height index n=4, Rheumatoid, 
Arthris n=4, Subtalar neutral 
n=8, Not interested n=9)
Completed session, n = 19 6 Week Follow-up, n = 19
Completed Session, n = 17
Lost to follow-up, n = 2 (moved overseas and CA 
treatment resumed)
12 Week Follow-up, n = 19
Passive Treatment (brace and 
stretching), n = 19
Acve Treatment (Brace and 
Strengthening), n = 20
Enrollment
Allocaon
6 week follow- up
12 week follow-up
Week 1 follow-up
Week 2 follow-up
Week 3 follow-up
Week 4 /5 follow-up
Completed session, n = 19
Completed session, n = 19
Completed session, n = 19
Completed session, n = 19
Completed session, n = 20
Completed session, n = 19
Lost to Follow-up, n=1 (decided to have surgery)
Completed session, n = 19
Completed session, n = 19
Figure 1. Consolidated Standards of Reporting Trials flow chart. 
 at GEORGE FOX UNIVERSITY on September 2, 2016fai.sagepub.comDownloaded from 
Houck et al 1011
12-week time points were associated with significantly bet-
ter scores compared with initial scores. However, there were 
no significant differences between the 6-week and 12-week 
time points for any of the SMFA dependent variables. In 
contrast to the FFI, between initial visit and 6 weeks, the 
change scores of the Mobility Index and Dysfunction Index 
of the SMFA were significantly higher in the strengthening 
group (Table 3). Further, the proportion of participants expe-
riencing a 10-point change significantly favored the strength-
ening group (Table 3). Significantly more participants in the 
strengthening group experienced an improvement above 10 
points for the Mobility Index and Dysfunction Index com-
pared with the stretching group from initial visit to 6 weeks. 
The significant change scores from initial visit to 6 weeks on 
the SMFA Mobility and Dysfunction Indexes were not 
accompanied by a significant change in the Bother Index. 
All other change scores from initial visit to 12 weeks for the 
SMFA were nonsignificant.
Due to the range of compliance observed in the 
strengthening and stretching groups, Pearson correlations 
between compliance and the primary outcome measures 
(FFI and SMFA) were explored. The relationships between 
compliance and FFI scales or compliance and SMFA 
scales were all weak and nonsignificant (r < 0.14).
Isometric Deep Posterior Compartment Strength
No significant interactions were detected between time and 
group for isometric deep posterior compartment strength, 
nor was there a main effect for time (Table 4). There were 
also no significant differences in change scores for isomet-
ric deep posterior compartment strength for any of the inter-
vals tested (Table 5). The proportion of participants who 
experienced improvement above a standard error of the 
measurement in strength was not significantly different in 
the strengthening group on the involved or uninvolved sides 
for any of the intervals tested.
Discussion
The new findings of this study are that a moderate-intensity, 
home-based exercise approach minimally improves out-
comes over orthosis alone in participants with stage II 
TPTD. There were significant differences favoring the 
strengthening treatment group associated with the Mobility 
and Dysfunction Indexes of the SMFA at 6 weeks. These 
improvements in mobility and function were not coupled 
with improvements in pain (FFI scores) or strength. Both 
groups improved during the initial interval of training from 
0 to 6 weeks on the FFI and SMFA.
A positive effect of the strengthening treatment was 
observed in the Mobility and Dysfunction Indexes of the 
SMFA; however, this was not coupled with parallel 
improvements in pain. During the initial 0- to 6-week period 
when participants learned how to progress their exercises, 
53% and 42% of the strengthening group improved their 
Mobility and Dysfunction Index scores, respectively, on the 
SMFA. This compared with only 18% and 12% for the 
same 2 SMFA Indexes in the stretching group (Table 2). 
Despite this effect on mobility, no differences between the 
strengthening and stretching groups were observed in the 
FFI scale or the Bother Index of the SMFA, which focus on 
the effect of pain and bother, respectively. Gains in ankle 
muscle strength or improved recruitment of muscles used 
for mobility might explain these mobility findings, while it 
may also be possible that increased mobility adversely 
affects any reduction in pain that might result from the 
strengthening program.
Alternatively, the strengthening treatment protocol may 
have lacked sufficient intensity and length to capture treat-
ment effects associated with pain and function in partici-
pants with stage II TPTD. Three studies, 1 controlled and 2 
uncontrolled, demonstrated significant benefits of exercise 
to augment orthosis treatment for stage II TPTD.1,17 In 
these studies, the intensity of the exercise and the length of 
the center-based treatments were greater than this study. 
Table 1. Comparison of Patient Characteristics, Foot Posture, 
Gait, and Self-Report of the Stretching Group (n = 17) and the 
Strengthening Group (n = 19) at the Initial Visit.
Stretching 
Groupa
Strengthening 
Groupa P Valueb
Patient characteristics
Age 58 ± 9 57 ± 12 .14
Height, cm 167 ± 9 166 ± 9 .99
Weight, kg 87 ± 15 82 ± 18 .43
Body mass index, kg/m2 31 ± 5 30 ± 6 .09
Male sex, n  4  4 .62c
Left side involvement, n 11 13 .45c
Foot posture
Arch height index 0.32 ± 0.03 0.32 ± 0.02 .20
Gait
Walk speed, m/s 1.1 ± 0.1 1.0 ± 0.1 .45
Self-report
Foot Function Index
 Activity Limitations 13 ± 12 16 ± 11 .60
 Disability 31 ± 16 40 ± 20 .10
 Pain 35 ± 11 38 ± 18 .08
 Total 26 ± 10 31 ± 13 .22
Short Musculoskeletal Function Assessment
 Mobility 22 ± 12 27 ± 14 .56
 Dysfunction 17 ± 9 22 ± 12 .38
 Bother 23 ± 16 26 ± 20 .81
aValues expressed as mean ± standard deviation, except for male sex 
and left side involvement.
bP values are from 2-sample t test for all comparisons, except those 
noted with “c.”
cChi-square test was used for these comparisons.
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Previous studies used either 10 weeks17 or 120 days (median 
treatment period)1 of center-based treatment combined with 
home exercise. This study used 6 center-based treatments 
followed by 6 weeks of home exercise, approximately 50% 
fewer center-based treatment sessions. The intensity of the 
exercise was also higher in previous studies. For example, a 
previous study16 used a custom-built jig with loaded springs 
that were increased from 0.9 kg to 1.7 kg (concentric group) 
or to 5.6 kg (eccentric group) over the study period of 10 
weeks. Another study1 used high-repetition exercise and 
isokinetic training coupled with large sets of heel raises and 
toe walking to strengthen participants. The current study, 
using a moderate-intensity home-based program that 
included heel raises and resisted deep posterior compart-
ment strengthening using elastic bands, did not replicate 
improvements in pain and function observed in these previ-
ous studies. In summary, high-exercise intensity over a lon-
ger period of time (ie, greater than 10 weeks) may show 
more definite benefits to participants with stage II TPTD.
The lack of increase in isometric deep posterior com-
partment strength (Table 4) may be associated with the 
intensity of training or the lack of large side-to-side defi-
cits in strength at the initial visit. Previous studies did not 
document weakness specific to the tibialis posterior mus-
cle.1,17 The initial average side-to-side ratio of deep poste-
rior compartment strength was 88% and 87% in the 
stretching and strengthening groups, respectively (Table 
4). The near 90% side-to-side strength ratio in this study 
sample suggests that this group had less side-to-side 
strength deficit than documented in previous studies.1,17,24 
Table 2. Comparison of Self-Report Scores of the Stretching Group (n = 17) and the Strengthening Group (n = 19).
Analysis of Variance
 Stretching Groupa Strengthening Groupa Time Interaction
Foot Function Indexb
Initial visit
 Activity Limitations 13 (7-18) 16 (11-21)  
 Disability 31 (23-38) 40 (31-49)  
 Pain 35 (29-40) 38 (29-46)  
 Total 26 (21-31) 31 (25-37)  
6 Weeks
 Activity Limitations 8 (4-12)c 8 (4-12)c  
 Disability 21 (15-27)c 21 (15-28)c  
 Pain 21 (15-28)c 21 (14-27)c  
 Total 17 (13-21)c 17 (12-22)c  
12 Weeks
 Activity Limitations 7 (3-10)c 10 (4-16)c .001 NS
 Disability 18 (12-24)c 24 (15-34)c <.001 NS
 Pain 18 (12-25)c 19 (11-27)c <.001 NS
 Total 14 (10-19)c 18 (11-25)c <.001 NS
Short Musculoskeletal Functional Assessmentd
Initial visit
 Mobility 22 (16-28) 27 (20-33)  
 Dysfunction 17 (12-21) 22 (17-28)  
 Bother 23 (15-31) 26 (17-35)  
6 Weeks
 Mobility 18 (13-24)c 15 (10-20)c  
 Dysfunction 13 (9-16)c 13 (9-17)c  
 Bother 14 (9-18)c 15 (9-21)c  
12 Weeks
 Mobility 16 (12-19)c 17 (12-22)c >.001 NS
 Dysfunction 12 (9-15)c 15 (10-19)c >.001 NS
 Bother 12 (9-15)c 16 (8-25)c >.001 NS
Abbreviation: NS, not significant (P > .05).
aValues expressed as mean (95% confidence interval);
bFoot Function Index values are reported in millimeters; lower scores indicate better function and less pain.
cIndicates significantly different post hoc test (P < .05) from baseline.
dShort Musculoskeletal Functional Assessment scores are reported as percentages; lower scores indicate better function.
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Separate from the discussion of the intensity of exercise, 
targeting participants with documented weakness may 
result in greater muscle responses and, therefore, more 
benefits to participants.
Use of a prefabricated orthosis and a stretching exercise 
program decreased self-reported pain, reduced disability, 
and increased activity in our sample of participants with 
stage II TPTD. Across the FFI scales (subscales and total), 
the stretching group improved between 4.4 and 18.4 mm 
from the initial visit to 6 weeks (Table 3). Approximately 
60% of participants in both groups experienced a greater 
than 10-mm improvement in their FFI-Total from the initial 
visit to 6 weeks (Table 3). We are unaware of any previous 
studies that used this orthosis; however, comparisons of 
other orthoses suggest that moderate improvements were 
observed in the current study. The shorter length of the 
study, differences in orthoses, and severity of TPTD are 
important to consider when comparing this study with oth-
ers that used orthosis strategies for TPTD. Interestingly, no 
studies, long or short term, report pain elimination using 
orthoses.1,2 The lack of resolution of symptoms, even with 
long-term orthosis treatment (4-8 years), motivates further 
research.
There are several significant limitations to this study 
associated with study design, sample characteristics, and 
alternative treatments. This stratified, randomized con-
trolled trial blinded participants but not the treating thera-
pist. Although this clinical trial restricted inclusion to 
participants with stage II TPTD, there was reported vari-
ability in the degree of foot deformity, strength, and 
Table 3. Comparison of Self-Report Change Scores of the Stretching Group (n = 17) and the Strengthening Group (n = 19).
Mean Change (95% CI) Participants Improved, % (n)
 Stretching Group Strengthening Group Stretching Group Strengthening Group
Foot Function Indexa
From initial visit to 6 weeks
 Activity Limitations 4 (2 to 7) 8 (2 to 14)  
 Disability 10 (5 to 15) 19 (12 to 26) 41 (7) 37 (7)
 Pain 13 (7 to 20) 17 (10 to 24) 59 (10) 53 (10)
 Total 9 (5 to 14) 15 (9 to 20) 65 (11) 63 (12)
From initial visit to 12 weeks
 Activity Limitations 6 (3 to 9) 6 (0 to 13)  
 Disability 13 (7 to 19) 16 (7 to 25) 29 (5) 47 (9)
 Pain 16 (8 to 24) 18 (10 to 27) 47 (8) 74 (14)
 Total 12 (6 to 18) 14 (7 to 20) 59 (10) 68 (13)
From 6 to 12 weeks
 Activity Limitations 2 (–1 to 4) −2 (–5 to 2)  
 Disability 3 (–1 to 7) −3 (–10 to 4) 18 (3) 5 (1)
 Pain 3 (–4 to 10) 1 (–5 to 8) 12 (2) 16 (3)
 Total 3 (–1 to 6) −1 (–6 to 3) 24 (4) 21 (4)
Short Musculoskeletal Functional Assessmentb
From initial visit to 6 weeks
 Mobility 4 (2 to 5) 11 (7 to 16)c 18 (3) 53 (10)d
 Dysfunction 4 (2 to 5) 9 (6 to 13)c 12 (2) 42 (8)d
 Bother 9 (5 to 14) 11 (6 to 16) 35 (6) 47 (9)
From initial visit to 12 weeks
 Mobility 7 (4 to 10) 10 (4 to 15) 29 (5) 53 (10)
 Dysfunction 5 (3 to 7) 8 (3 to 12) 24 (4) 32 (6)
 Bother 11 (6 to 16) 9 (3 to 16) 35 (6) 42 (8)
From 6 to 12 weeks
 Mobility 3.0 (–1 to 7) −2 (–5 to 2) 24 (4) 5 (1)
 Dysfunction 1 (–1 to 3) −2 (–4 to 1) 6 (1) 5 (1)
 Bother 2 (–1 to 5) −1 (–6 to 3) 12 (2) 11 (2)
aFoot Function Index values are reported in millimeters (maximum 100). Minimal clinically important difference was used to calculate proportions as 
follows: Activity Limitations, none used; Disability, 6.7; Pain, 12.3; and Total, 6.5.
bShort Musculoskeletal Functional Assessment scores are reported as percentages (maximum 100). Responsiveness to change of 10 points was used to 
calculate proportions for the Mobility, Dysfunction, and Bother Indexes.
cSignificantly different according to t test (P < .05).
dSignificantly different proportion according to chi-square test (P < .05).
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symptoms.24 Differences in initial strength across various 
studies may also affect study results. For example, a more 
targeted sample of participants with documented weakness 
at the start of the trial may have demonstrated improve-
ments in response to exercise. The sample size was suffi-
cient to detect effect sizes of 6.75 mm on the FFI-Total 
(approximately equal to a minimal clinically important dif-
ference of 6.5 mm). However, the confidence intervals do 
not exclude the possibility of a significant effect. For exam-
ple, the confidence interval of the change scores for FFI-
Pain from the initial visit to 6 weeks ranges from 10 to 26 
points for the strengthening group (Table 3). Either a larger 
sample or more defined sample criteria (ie, weaker partici-
pants at initial visit) may narrow the confidence intervals 
and subsequently avoid a type II error. Further, the length of 
the study was short and therefore does not take into account 
gradual effects of the strengthening intervention that could 
occur over time. Alternative interventions such as activity 
limitation and immobilization alone were not separated as 
treatment strategies in this clinical trial. In summary, study 
design, sample characteristics, intervention intensity, and 
alternative interventions are important considerations in 
future clinical trials.
In conclusion, a moderate-intensity, home-based exer-
cise program was minimally effective in augmenting ortho-
sis wear alone in participants with stage II TPTD. The 
improvements observed were smaller than those reported in 
some previous controlled and uncontrolled clinical trials, 
suggesting that positive effects on function and pain in 
response to exercise may require higher intensity than this 
home-based program for participants with TPTD. 
Irrespective of the specific exercise protocol (ie, stretching 
or strengthening), participants improved in pain and func-
tion in response to either a strengthening or a stretching 
approach over a 12-week time period.
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Table 4. Comparison of Strength Measures of the Stretching Group (n = 17) and the Strengthening Group (n = 19).
Involved Side, N/kga Uninvolved Side, N/kga Ratio of Involved to Uninvolved
Initial visit
 Stretching 0.8 (0.7-0.9) 0.9 (0.81-1.0) 0.9 ± 0.3
 Strengthening 0.7 (0.6-0.8) 0.8 (0.7-0.89) 0.9 ± 0.2
6 weeks
 Stretching 0.8 (0.7-1.0) 1.0 (0.9-1.1) 0.9 ± 0.2
 Strengthening 0.8 (0.7-0.9) 0.8 (0.8-0.9) 0.9 ± 0.2
12 weeks
 Stretching 0.8 (0.7-0.9) 1.0 (0.9-1.1) 0.9 ± 0.2
 Strengthening 0.8 (0.7-0.9) 0.9 (0.8-0.9) 0.9 ± 0.2
Main effect—time NS NS NS
Interaction effect NS NS NS
Abbreviation: NS, not significant (P > .05).
aValues expressed as mean (95% CI).
Table 5. Comparison of Change in Strength of the Stretching Group (n = 17) and the Strengthening Group (n = 19).
Mean Change, N/kg (95% CI) Participants Improved, % (n)
 Involved Side Uninvolved Side Involved Sidea Uninvolved Sidea
From initial visit to 6 weeks
 Stretching 0.1 (–0.0 to 0.1) 0.0 (–0.1 to 0.1) 11 (2) 29.4 (5)
 Strengthening 0.1 (–0.0 to 0.2) 0.0 (–0.1 to 0.1) 31.5 (6) 21.1 (4)
From initial visit to 12 weeks
 Stretching 0.0 (–0.0 to 0.1) 0.1(–0.1 to 0.2) 29.4 (5) 35.2 (6)
 Strengthening 0.1 (–0.0 to 0.2) 0.0(0.0 to 0.1) 36.8 (7) 21.1 (4)
From 6 weeks to 12 weeks
 Stretching 0.0 (–0.1 to 0.0) 0.0 (–0.1 to 0.1) 5.9 (1) 17.6 (3)
 Strengthening 0.0 (–0.1 to 0.1) 0.0 (–0.1 to 0.0) 26.3 (5) 10.5 (2)
aProportions were determined by 2 standard errors of the measurement.
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